Article Details

AstraZeneca's Anemia Drug Sees Setback At FDA Committee

Retrieved on: 2021-07-17 00:45:00

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Anemia Drug Sees Setback At FDA Committee. View article details on hiswai:

Excerpt

AstraZeneca has been involved in working on the treatment for years, having inked a deal with partner FibroGen to develop roxadustat in 2013, ...

Article found on: www.law360.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up